Clinical Trials Directory

Trials / Completed

CompletedNCT00831259

Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)

Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale: a Prospective Diffusion-weighted Magnetic Resonance Imaging Study.

Status
Completed
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Pulmonary embolism is associated with a small but definite risk of paradoxical embolism in patients with a patent foramen ovale (PFO). While neurologic complications are unfrequent the incidence of clinically silent brain infarction is unknown. We will assess the rate of clinically apparent and silent cerebral embolism in patients with a pulmonary embolism (PE) in relation to the presence or not of a PFO.

Conditions

Timeline

Start date
2007-10-01
Primary completion
2009-04-01
Completion
2009-05-01
First posted
2009-01-28
Last updated
2011-05-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00831259. Inclusion in this directory is not an endorsement.

Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO) (NCT00831259) · Clinical Trials Directory